Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2000 Sep 4;83(7):935–940. doi: 10.1054/bjoc.2000.1421

Pulmonary availability of isotretinoin in rats after inhalation of a powder aerosol

S M Raleigh 1, R D Verschoyle 1, C Bowskill 1, U Pastorino 2, J N Staniforth 3, F Steele 3, D Dinsdale 1, P Carthew 1, C K Lim 1, J Silvester 4, A Gescher 1
PMCID: PMC2374686  PMID: 10970697

Abstract

Repeated oral administration of chemopreventive retinoids such as isotretinoin over extended periods of time is associated with intolerable systemic toxicity. Here isotretinoin was formulated as a powder aerosol, and its delivery to the lungs of rats was studied with the aim to explore the possibility of minimizing adverse effects associated with its oral administration. Rats received isotretinoin orally (0.5, 1 or 10 mg kg–1) or by inhalation (theoretical dose ~1 or ~10 mg kg–1) in a nose-only inhalation chamber. Isotretinoin was quantitated by high-pressure liquid chromatography in plasma and lung tissue. The ratios of mean area of concentration-vs-time curve (AUC) values in the lungs over mean AUCs in the plasma for isotretinoin following single or repeated aerosol exposure surpassed those determined for the oral route by factors of between two (single low-dose) and five (single high-dose). Similarly, the equivalent ratios for the maximal peak concentrations in lungs and plasma obtained after aerosol exposure consistently exceeded those seen after oral administration, suggesting that lungs were exposed to higher isotretinoin concentrations after aerosol inhalation than after oral administration of similar doses. Repeated high doses of isotretinoin by inhalation resulted in moderate loss of body weight, but microscopic investigation of ten tissues including lung and oesophagus did not detect any significant aerosol-induced damage. The results suggest that administration of isotretinoin via powder aerosol inhalation is probably superior to its application via the oral route in terms of achieving efficacious drug concentrations in the lungs. © 2000 Cancer Research Campaign

Keywords: aerosol delivery, chemoprevention, retinoids, pharmacokinetics

Full Text

The Full Text of this article is available as a PDF (99.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahn M. J., Langenfeld J., Moasser M. M., Rusch V., Dmitrovsky E. Growth suppression of transformed human bronchial epithelial cells by all-trans-retinoic acid occurs through specific retinoid receptors. Oncogene. 1995 Dec 7;11(11):2357–2364. [PubMed] [Google Scholar]
  2. Boyle J. O., Langenfeld J., Lonardo F., Sekula D., Reczek P., Rusch V., Dawson M. I., Dmitrovsky E. Cyclin D1 proteolysis: a retinoid chemoprevention signal in normal, immortalized, and transformed human bronchial epithelial cells. J Natl Cancer Inst. 1999 Feb 17;91(4):373–379. doi: 10.1093/jnci/91.4.373. [DOI] [PubMed] [Google Scholar]
  3. Gagnon R. C., Peterson J. J. Estimation of confidence intervals for area under the curve from destructively obtained pharmacokinetic data. J Pharmacokinet Biopharm. 1998 Feb;26(1):87–102. doi: 10.1023/a:1023228925137. [DOI] [PubMed] [Google Scholar]
  4. Grunberg S. M., Itri L. M. Phase II study of isotretinoin in the treatment of advanced non-small cell lung cancer. Cancer Treat Rep. 1987 Nov;71(11):1097–1098. [PubMed] [Google Scholar]
  5. Hixson E. J., Burdeshaw J. A., Denine E. P., Harrison S. D., Jr Comparative subchronic toxicity of all-trans- and 13-cis- retinoic acid in Sprague--Dawley rats. Toxicol Appl Pharmacol. 1979 Feb;47(2):359–365. doi: 10.1016/0041-008x(79)90331-4. [DOI] [PubMed] [Google Scholar]
  6. Hong W. K., Endicott J., Itri L. M., Doos W., Batsakis J. G., Bell R., Fofonoff S., Byers R., Atkinson E. N., Vaughan C. 13-cis-retinoic acid in the treatment of oral leukoplakia. N Engl J Med. 1986 Dec 11;315(24):1501–1505. doi: 10.1056/NEJM198612113152401. [DOI] [PubMed] [Google Scholar]
  7. Hong W. K., Lippman S. M., Itri L. M., Karp D. D., Lee J. S., Byers R. M., Schantz S. P., Kramer A. M., Lotan R., Peters L. J. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990 Sep 20;323(12):795–801. doi: 10.1056/NEJM199009203231205. [DOI] [PubMed] [Google Scholar]
  8. Kalin J. R., Wells M. J., Hill D. L. Disposition of 13-cis-retinoic acid and N-(2-hydroxyethyl)retinamide in mice after oral doses. Drug Metab Dispos. 1982 Jul-Aug;10(4):391–398. [PubMed] [Google Scholar]
  9. Kerr I. G., Lippman M. E., Jenkins J., Myers C. E. Pharmacology of 13-cis-retinoic acid in humans. Cancer Res. 1982 May;42(5):2069–2073. [PubMed] [Google Scholar]
  10. Lanvers C., Hempel G., Blaschke G., Boos J. Simultaneous determination of all-trans-, 13-cis- and 9-cis-retinoic acid, their 4-oxo metabolites and all-trans-retinol in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Appl. 1996 Oct 25;685(2):233–240. doi: 10.1016/s0378-4347(96)00192-2. [DOI] [PubMed] [Google Scholar]
  11. Lee J. S., Lippman S. M., Benner S. E., Lee J. J., Ro J. Y., Lukeman J. M., Morice R. C., Peters E. J., Pang A. C., Fritsche H. A., Jr Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia. J Clin Oncol. 1994 May;12(5):937–945. doi: 10.1200/JCO.1994.12.5.937. [DOI] [PubMed] [Google Scholar]
  12. Lotan R. Retinoids in cancer chemoprevention. FASEB J. 1996 Jul;10(9):1031–1039. doi: 10.1096/fasebj.10.9.8801164. [DOI] [PubMed] [Google Scholar]
  13. Lotan R., Xu X. C., Lippman S. M., Ro J. Y., Lee J. S., Lee J. J., Hong W. K. Suppression of retinoic acid receptor-beta in premalignant oral lesions and its up-regulation by isotretinoin. N Engl J Med. 1995 May 25;332(21):1405–1410. doi: 10.1056/NEJM199505253322103. [DOI] [PubMed] [Google Scholar]
  14. Parthasarathy R., Gilbert B., Mehta K. Aerosol delivery of liposomal all-trans-retinoic acid to the lungs. Cancer Chemother Pharmacol. 1999;43(4):277–283. doi: 10.1007/s002800050895. [DOI] [PubMed] [Google Scholar]
  15. Virchow J. C., Jr, Kroegel C., Matthys H. Antiasthma drug delivery. What is on the horizon? Clin Pharmacokinet. 1994 Aug;27(2):85–93. doi: 10.2165/00003088-199427020-00001. [DOI] [PubMed] [Google Scholar]
  16. Wattenberg L. W., Wiedmann T. S., Estensen R. D., Zimmerman C. L., Steele V. E., Kelloff G. J. Chemoprevention of pulmonary carcinogenesis by aerosolized budesonide in female A/J mice. Cancer Res. 1997 Dec 15;57(24):5489–5492. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES